Form 4 for SGHT Sight Sciences, Inc.
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-16 · accession 0001193125-25-325277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | 2025-12-16 | SGHT | Encrantz Staffan | Dir, 10% | P - Purchase | $8.31 | +14.0K | 1.39M | +1% | +$116.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | P | A | 13,958 | $8.31 | 1,391,922 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $8.12 to $8.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) Includes (i)1,360,970 shares of Common Stock and (ii) 30,952 restricted stock units which are subject to vesting as previously reported. |